Oxford PV collaborates with HZB to move perovskite solar cells closer to commercialisation
Oxford PV – The Perovskite Company's industrial site in Brandenburg an der Havel, Germany where the company is working rapidly to transfer its advanced perovskite on silicon tandem solar cell technology to an industrial scale process. © Oxford PV
Perovskite solar technology leader Oxford PV collaborates with leading German research centre to support the accelerated transfer of its technology into silicon cell manufacturing lines.
Oxford PVTM – The Perovskite CompanyTM, the leader in the field of perovskite solar cells, today announced its collaboration with Helmholtz-Zentrum Berlin (HZB), the leading German research centre focused on energy materials research.
Oxford PV has made considerable progress in transferring its advanced perovskite on silicon tandem solar cell technology from its laboratory in Oxford, UK to an industrial scale process at its site in Brandenburg an der Havel, Germany.
HZB’s extensive expertise in silicon heterojunctions solar cell technology, will support Oxford PV to further optimise its perovskite on silicon tandem solar cell technology, and demonstrate production scale up, to ensure ease of integration into large scale silicon solar cell and module production.
“Working with HZB to understand solar cell manufacturers’ silicon cells, will allow Oxford PV’s perovskite on silicon tandem formation to be fully optimised, to ensure the most efficient tandem solar cell, and the easy transfer of our technology into our commercial partner’s industrial processes, commented Chris Case, Chief Technology Officer, at Oxford PV,
“Oxford PV is now in the final stage of commercialising its perovskite photovoltaic solution, which has the potential to enable efficiency gains that will transform the economics of silicon photovoltaic technology globally.”
Rutger Schlatmann, Director of the PVcomB institute at HZB, said, “HZB believe that perovskites present a significant opportunity to the future of photovoltaics. For this reason, at our new innovation lab - HySPRINT, we have significantly increased our expertise and attracted some of the most promising young scientists in this field. HZB’s collaboration with Oxford PV is strategically important to the institute, as Oxford PV is the ideal partner to further develop our solar cell technology knowledge and help support the commercialisation of tandem silicon perovskite photovoltaic cells.”
More Information:
- Oxford PV
- PVcomB
- HySPRINT-a Helmholtz Innovation Lab
- Berlin Battery Lab: BAM, HZB and HU are conducting joint research on sodium batteriesThe Federal Institute for Materials Research and Testing (BAM), the Helmholtz Zentrum Berlin (HZB) and Humboldt-Universität zu Berlin (HU) today officially inaugurated the Berlin Battery Lab (BBL). At this new research platform, BAM, HZB and HU jointly develop and test resource-efficient battery technologies with a focus on sodium-based systems. Together, they develop new materials, investigate innovative cell chemistries, and produce battery prototypes. The research infrastructure of the Berlin Battery Lab is also open to external partners from science and industry and is designed to accelerate the transfer from research to application.
- Humboldt-Fellow at HZB Institute for Solar Fuels: Kayode Adesina AdegokeKayode Adesina Adegoke is a renowned chemist, affiliated with LAUTECH SDG 11 (Sustainable Cities and Communities Research Group), Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, Ogbomoso, Nigeria. He is collaborating with Matthew Mayer to investigate the degradation of electrocatalysts during electrochemical CO₂ reduction. The Alexander von Humboldt Fellowship enables him to stay at Helmholtz Zentrum Berlin up to 24 months.
- Protein crystallography at BESSY II: faster, better and more and more automaticMany diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with Manfred Weiss, head of the research group for macromolecular crystallography.